Key result
A history of heart disease with current medication significantly increased the risk of postoperative morbidity following radical gastrectomy (OR 6.7; 95% CI 1.5-29.9; P=0.01).
Why the study?
Does the presence of comorbid heart disease or chronic liver disease increase postoperative morbidity in patients undergoing radical gastrectomy for gastric cancer?
Cohort (n=759)
Does the presence of comorbid heart disease or chronic liver disease increase postoperative morbidity in patients undergoing radical gastrectomy for gastric cancer?
Odds Ratio: 6.7 (95% CI 1.5–29.9)
p-value: p=0.01
Heart disease and chronic liver disease are significant risk factors for increased postoperative morbidity following radical gastrectomy.
No takes yet. Share an insight, caveat, or question.
Supports cardiac risk stratification before gastrectomy; leaves open whether optimization reduces morbidity in this observational cohort.
Jeong et al. (2010) conducted a cohort in Gastric cancer (n=759). Heart disease vs. No heart disease was evaluated on Postoperative morbidity (OR 6.7, 95% CI 1.5-29.9, p=0.01). A history of heart disease with current medication significantly increased the risk of postoperative morbidity following radical gastrectomy (OR 6.7; 95% CI 1.5-29.9; P=0.01).